Abstract
Introduction Deafness is the most common human sensory deficit. Cochlear implantation is the primary intervention for severe-to-profound deafness. Currently, over 7000 people have bilateral cochlear implants (CIs) in the United Kingdom (UK), most of whom are children. Patient feedback suggests that for children with bilateral CIs, everyday communication is challenging and tiring, with extra effort required to integrate information from two ears, especially in noise, and that current rehabilitation techniques are not engaging, or appropriate to their lifestyles. To address these issues, researchers developed the Both EARS (BEARS) training package comprised of three virtual reality games to improve sound localization and listening in noise.
Objectives This protocol describes the design and methodology of a multi-center phase III randomized controlled trial (RCT) to evaluate whether use of the BEARS training package alongside usual care compared to only receiving usual care improves speech-in-noise perception, hearing experiences, vocabulary and quality of life and reduces listening effort in children and young people (aged 8 -16 years (inclusive) with bilateral CIs.
Methods This RCT is currently underway in 16 clinical CI departments in National Health Service or university hospitals across the UK. The intervention involves 3 months of spatial-listening training delivered via the BEARS training package in addition to any routine rehabilitation. The control is ‘usual care’ (routine rehabilitation clinical care pathway). The primary outcome is the difference between the intervention groups in speech-in-noise perception score at 3 months derived from the spatial speech in noise (SSiN-VA) test. Recruitment closes at the end of the day on 31st July 2026, and end of data collection is 31st October 2026. Data analyses will be reported by 31st March 2026.
Significance This is the largest known trial of children and young people with bilateral CIs. It will generate high-quality evidence on speech-in-noise outcomes and inform training interventions to improve spatial listening.
Trial registration ClinicalTrials.gov registration: NCT05808543; UK’s clinical study registry (ISRCTN92454702)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ClinicalTrials.gov registration - NCT05808543, https://clinicaltrials.gov/study/NCT05808543 UK's clinical study registry (ISRCTN92454702)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Yorkshire & The Humber - Sheffield Research Ethics Committee (Integrated Research Application System (IRAS) project ID: 319903 REC reference: 23/YH/0046)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funder and Sponsor This project is funded by a National Institute of Health and Care Research (NIHR) Programme Grant for Applied Research (NIHR PGfAR 201608). The study is sponsored by Guy’s and St Thomas’ NHS Foundation Trust (GSTT). GSTT has no influence on study design, data collection, analysis and interpretation of data, writing of the report and the decision to submit for publication. GSTT has responsibility to ensure that the clinical trial is conducted in accordance with Good Clinical Practice (GCP) guidelines. NIHR will check manuscripts prior to submission to ensure that appropriate acknowledgements are in place.
Competing interests No potential conflicts of interest are reported by the authors, the principal investigators or steering committee members.
Trial Registration ClinicalTrials.gov registration - NCT05808543, https://clinicaltrials.gov/study/NCT05808543. Date of Registration in Primary Registry was 17 March 2023. This manuscript relates to protocol version 7.0, 14th July 2026. It was reviewed by the Yorkshire & The Humber - Sheffield Research Ethics Committee (Integrated Research Application System (IRAS) project ID: 319903; REC reference: 23/YH/0046). It is also registered on the UK’s clinical study registry (ISRCTN92454702).
Data availability No datasets were generated or analyzed during the current study. All relevant data from this study will be made available upon study completion.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
